Cipla informs about Press Release

04 Jun 2015 Evaluate

Cipla has informed about Press Release dated June 03, 2015 titled ‘Cipla Announces US FDA Approval for the World's First Paediatric Lopinavir and ritonavir Oral Pellets for the Treatment of AIDS in Infants and Young Children’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1357.80 12.10 (0.90%)
26-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1784.60
Dr. Reddys Lab 1318.90
Cipla 1357.80
Zydus Lifesciences 938.15
Lupin 2323.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×